144 related articles for article (PubMed ID: 11298625)
1. Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome.
Kjellman P; Learoyd DL; Messina M; Weber G; Höög A; Wallin G; Larsson C; Robinson BG; Zedenius J
Br J Surg; 2001 Apr; 88(4):557-63. PubMed ID: 11298625
[TBL] [Abstract][Full Text] [Related]
2. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas.
Learoyd DL; Messina M; Zedenius J; Guinea AI; Delbridge LW; Robinson BG
J Clin Endocrinol Metab; 1998 Oct; 83(10):3631-5. PubMed ID: 9768676
[TBL] [Abstract][Full Text] [Related]
3. Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas.
Puxeddu E; Moretti S; Giannico A; Martinelli M; Marino C; Avenia N; Cristofani R; Farabi R; Reboldi G; Ribacchi R; Pontecorvi A; Santeusanio F
Eur J Endocrinol; 2003 May; 148(5):505-13. PubMed ID: 12720532
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].
Zhu XL; Zhou XY; Zhang TM; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):87-91. PubMed ID: 16630482
[TBL] [Abstract][Full Text] [Related]
5. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.
Liu RT; Chou FF; Wang CH; Lin CL; Chao FP; Chung JC; Huang CC; Wang PW; Cheng JT
Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154
[TBL] [Abstract][Full Text] [Related]
6. [Rearrangement of the RET gene in papillary thyroid carcinoma].
Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
[TBL] [Abstract][Full Text] [Related]
8. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
[TBL] [Abstract][Full Text] [Related]
9. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
[TBL] [Abstract][Full Text] [Related]
10. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas.
Lee CH; Hsu LS; Chi CW; Chen GD; Yang AH; Chen JY
J Clin Endocrinol Metab; 1998 May; 83(5):1629-32. PubMed ID: 9589668
[TBL] [Abstract][Full Text] [Related]
11. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
[TBL] [Abstract][Full Text] [Related]
12. Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.
Mayr B; Pötter E; Goretzki P; Rüschoff J; Dietmaier W; Hoang-Vu C; Dralle H; Brabant G
Br J Cancer; 1998 Mar; 77(6):903-6. PubMed ID: 9528832
[TBL] [Abstract][Full Text] [Related]
13. RET oncogene activation in papillary thyroid carcinoma.
Tallini G; Asa SL
Adv Anat Pathol; 2001 Nov; 8(6):345-54. PubMed ID: 11707626
[TBL] [Abstract][Full Text] [Related]
14. Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms?
Soares P; Fonseca E; Wynford-Thomas D; Sobrinho-Simões M
J Pathol; 1998 May; 185(1):71-8. PubMed ID: 9713362
[TBL] [Abstract][Full Text] [Related]
15. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus.
Smida J; Salassidis K; Hieber L; Zitzelsberger H; Kellerer AM; Demidchik EP; Negele T; Spelsberg F; Lengfelder E; Werner M; Bauchinger M
Int J Cancer; 1999 Jan; 80(1):32-8. PubMed ID: 9935226
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of RET tyrosine kinase activation in Mexican patients with papillary thyroid carcinomas.
Martínez I; Mantilla A; Medrano ME; Hernández R; Hernández DM; Lazos M; Santiago H; González B; Hidalgo A; Salcedo M
Endocr Pathol; 2001; 12(2):113-23. PubMed ID: 11579677
[TBL] [Abstract][Full Text] [Related]
17. [Molecular analysis of structural abnormalities in papillary thyroid carcinoma gene].
Vasil'ev EV; Rumiantsev PO; Saenko VA; Il'in AA; Poliakova EIu; Nemtsova MV; Zaletaev DV
Mol Biol (Mosk); 2004; 38(4):642-53. PubMed ID: 15456136
[TBL] [Abstract][Full Text] [Related]
18. RET/PTC rearrangement in thyroid tumors.
Nikiforov YE
Endocr Pathol; 2002; 13(1):3-16. PubMed ID: 12114746
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of papillary thyroid carcinoma is facilitated by using an RT-PCR approach on laser-microdissected archival material to detect RET oncogene activation.
Lahr G; Stich M; Schütze K; Blümel P; Pösl H; Nathrath WB
Pathobiology; 2000; 68(4-5):218-26. PubMed ID: 11279350
[TBL] [Abstract][Full Text] [Related]
20. Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma.
Rhoden KJ; Johnson C; Brandao G; Howe JG; Smith BR; Tallini G
Lab Invest; 2004 Dec; 84(12):1557-70. PubMed ID: 15502856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]